よむ、つかう、まなぶ。
08参考資料１ ヒトパピローマウイルス（HPV）ワクチンファクトシート追補版 (71 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_63875.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第31回 9／25）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
(HPV) vaccine Changes under the National Immunisation Program in 2023 Fact Sheet. 2023.
Available from:
https://www.health.gov.au/sites/default/files/2023-02/hpv-vaccine-fact-sheet-
outlining-changes-under-the-national-immunisation-program-in-2023.pdf
101.
Australian Government Department of Health and Aged Care. National Immunisation
Program Schedule. 2023. Available from:
https://www.health.gov.au/sites/default/files/2023-
03/national-immunisation-program-schedule.pdf
102.
WHO.
Global
market
study:
HPV
vaccines.
2022.
Available
from:
https://www.who.int/publications/m/item/who-hpv-vaccine-global-market-study-april-2022
103.
WHO. Human papillomavirus vaccines: WHO position paper (2022 update). Weekly
epidemiological record. 2022;97(50):645–72.
104.
UNICEF. Human Papillomavirus Vaccine: Supply and Demand Update. 2020. Available
from: https://www.unicef.org/supply/media/5406/file/Human-Papillomavirus-Vaccine-MarketUpdate-October2020.pdf
105.
Van Damme P, Meijer C, Kieninger D, Schuyleman A, Thomas S, Luxembourg A,
et al. A phase III clinical study to compare the immunogenicity and safety of the 9-valent
and quadrivalent HPV vaccines in men. Vaccine. 2016;34(35):4205-12.
71
Available from:
https://www.health.gov.au/sites/default/files/2023-02/hpv-vaccine-fact-sheet-
outlining-changes-under-the-national-immunisation-program-in-2023.pdf
101.
Australian Government Department of Health and Aged Care. National Immunisation
Program Schedule. 2023. Available from:
https://www.health.gov.au/sites/default/files/2023-
03/national-immunisation-program-schedule.pdf
102.
WHO.
Global
market
study:
HPV
vaccines.
2022.
Available
from:
https://www.who.int/publications/m/item/who-hpv-vaccine-global-market-study-april-2022
103.
WHO. Human papillomavirus vaccines: WHO position paper (2022 update). Weekly
epidemiological record. 2022;97(50):645–72.
104.
UNICEF. Human Papillomavirus Vaccine: Supply and Demand Update. 2020. Available
from: https://www.unicef.org/supply/media/5406/file/Human-Papillomavirus-Vaccine-MarketUpdate-October2020.pdf
105.
Van Damme P, Meijer C, Kieninger D, Schuyleman A, Thomas S, Luxembourg A,
et al. A phase III clinical study to compare the immunogenicity and safety of the 9-valent
and quadrivalent HPV vaccines in men. Vaccine. 2016;34(35):4205-12.
71